A Phase I Study of Temozolomide (Temodar®) in Pediatric Patients with Relapsed or Refractory Leukemia—A Children's Oncology Group Study.
Autor: | Horton, Terzah M., Dolan, Eileen *, Hegde, Madhuri *, Berg, Stacey L. *, Adamson, Peter *, Blaney, Susan M. * |
---|---|
Zdroj: | In Blood 16 November 2005 106(11):4455-4455 |
Databáze: | ScienceDirect |
Externí odkaz: |